$AGEN
AGENUS INC Stock $agen

$agen Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-K Financial Statement

#000156459021013619 Filed on March 16, 2021

Income Statement

Concept	2020 Q4	2020 Q3	2020 Q2
Revenue	$31.27M	$14.83M	$26.95M
YoY Change	-9.38%	-25.62%	71.46%
Cost Of Revenue	$800.0K	$911.0K	$634.0K
YoY Change
Gross Profit	$30.46M	$13.92M	$26.31M
YoY Change
Gross Profit Margin	97.43%	93.86%	97.65%
Selling, General & Admin	$20.03M	$14.38M	$14.20M
YoY Change	62.58%	24.93%	24.45%
% of Gross Profit	65.76%	103.3%	53.97%
Research & Development	$35.57M	$32.13M	$38.55M
YoY Change	-3.42%	-30.34%	-14.79%
% of Gross Profit	116.78%	230.83%	146.52%
Depreciation & Amortization	$1.840M	$1.850M	$1.790M
YoY Change	10.84%	10.12%	6.55%
% of Gross Profit	6.04%	13.29%	6.8%
Operating Expenses	$55.60M	$32.13M	$38.55M
YoY Change	3.38%	-42.47%	-14.79%
Operating Profit	-$25.14M	-$18.21M	-$33.27M
YoY Change			-19.13%
Interest Expense	-$12.77M	-$16.21M	-$14.63M
YoY Change	7.76%	52.05%	49.33%
% of Operating Profit
Other Income/Expense, Net	$180.0K	-$650.0K	-$340.0K
YoY Change	-35.71%	-316.67%	-63.2%
Pretax Income	-$37.73M	-$51.65M	-$48.24M
YoY Change	22.3%	11.6%	-7.0%
Income Tax
% Of Pretax Income
Net Earnings	-$37.73M	-$51.65M	-$48.24M
YoY Change	22.3%	11.6%	-6.99%
Net Earnings / Revenue	-120.68%	-348.21%	-179.05%
Basic Earnings Per Share		-$0.28
Diluted Earnings Per Share	-$194.9K	-$0.28	-$280.7K
COMMON SHARES
Basic Shares Outstanding		182.7K
Diluted Shares Outstanding		182.7K

Balance Sheet

Concept	2020 Q4	2020 Q3	2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$99.90M	$114.1M	$79.20M
YoY Change	61.65%	22.29%	-34.92%
Cash & Equivalents	$99.87M	$114.1M	$79.17M
Short-Term Investments
Other Short-Term Assets	$2.009M	$9.900M	$9.000M
YoY Change	97.93%	-13.91%	538.75%
Inventory
Prepaid Expenses	$10.75M
Receivables	$1.157M	$1.400M	$16.60M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$113.8M	$125.5M	$104.8M
YoY Change	31.49%	17.07%	-24.57%
LONG-TERM ASSETS
Property, Plant & Equipment	$26.79M	$41.70M	$43.50M
YoY Change	1.76%	27.52%	70.55%
Goodwill	$25.45M	$24.69M	$24.28M
YoY Change	9.76%		5.39%
Intangibles	$10.89M	$11.15M	$11.76M
YoY Change	3.64%		3.01%
Long-Term Investments
YoY Change
Other Assets	$4.123M	$1.500M	$1.500M
YoY Change	190.97%	15.38%	23.56%
Total Long-Term Assets	$100.7M	$79.00M	$81.00M
YoY Change	46.41%	16.86%	19.52%
TOTAL ASSETS
Total Short-Term Assets	$113.8M	$125.5M	$104.8M
Total Long-Term Assets	$100.7M	$79.00M	$81.00M
Total Assets	$214.5M	$204.5M	$185.8M
YoY Change	38.1%	16.99%	-10.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$17.02M	$20.50M	$20.70M
YoY Change	25.44%	25.0%	8.65%
Accrued Expenses	$29.06M	$21.80M	$27.45M
YoY Change	-7.26%	-27.56%	18.19%
Deferred Revenue	$17.19M
YoY Change	-41.09%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$833.0K	$1.900M	$2.200M
YoY Change	28.95%	-86.52%	-83.92%
Total Short-Term Liabilities	$129.9M	$146.9M	$142.3M
YoY Change	6.28%	10.53%	16.89%
LONG-TERM LIABILITIES
Long-Term Debt	$18.88M	$19.10M	$19.30M
YoY Change	41.1%
Other Long-Term Liabilities	$1.514M	$217.9M	$223.3M
YoY Change	-63.87%	5230.23%	7100.9%
Total Long-Term Liabilities	$20.39M	$237.0M	$242.6M
YoY Change	16.07%	5697.46%	7723.28%
TOTAL LIABILITIES
Total Short-Term Liabilities	$129.9M	$146.9M	$142.3M
Total Long-Term Liabilities	$20.39M	$237.0M	$242.6M
Total Liabilities	$150.3M	$376.1M	$377.5M
YoY Change	7.51%	8.2%	202.39%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.466B	-$1.400B	-$1.400B
YoY Change	14.08%	11.56%	15.75%
Common Stock	$1.961M
YoY Change	42.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$203.7M	-$171.6M	-$191.7M
YoY Change
Total Liabilities & Shareholders Equity	$214.5M	$204.5M	$185.8M
YoY Change	38.1%	16.99%	-10.11%

Cashflow Statement

Concept	2020 Q4	2020 Q3	2020 Q2
OPERATING ACTIVITIES
Net Income	-$37.73M	-$51.65M	-$48.24M
YoY Change	22.3%	11.6%	-6.99%
Depreciation, Depletion And Amortization	$1.840M	$1.850M	$1.790M
YoY Change	10.84%	10.12%	6.55%
Cash From Operating Activities	-$35.59M	-$31.63M	-$37.37M
YoY Change	11.99%	13.86%	-191.37%
INVESTING ACTIVITIES
Capital Expenditures	-$840.0K	-$870.0K	-$1.120M
YoY Change	-20.75%	3.57%	-11.11%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$10.00K	-$970.0K
YoY Change
Cash From Investing Activities	-$830.0K	-$880.0K	-$2.090M
YoY Change	-21.7%	4.76%	65.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	24.65M	67.28M	26.32M
YoY Change	1856.35%	168100.0%	-33000.0%
NET CHANGE
Cash From Operating Activities	-35.59M	-31.63M	-37.37M
Cash From Investing Activities	-830.0K	-880.0K	-2.090M
Cash From Financing Activities	24.65M	67.28M	26.32M
Net Change In Cash	-11.77M	34.77M	-13.14M
YoY Change	-62.73%	-221.66%	-64.1%
FREE CASH FLOW
Cash From Operating Activities	-$35.59M	-$31.63M	-$37.37M
Capital Expenditures	-$840.0K	-$870.0K	-$1.120M
Free Cash Flow	-$34.75M	-$30.76M	-$36.25M
YoY Change	13.12%	14.18%	-185.98%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y5M19D
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y5M19D
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y1M17D
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P11Y10M24D
CY2020Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y1M6D
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	61808000
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	47201000
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	42861000
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7364000
CY2019Q4	us-gaap	Goodwill Goodwill	23188000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11841000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9431000
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10504000
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1417000
CY2019Q4	us-gaap	Assets Assets	155335000
CY2019	us-gaap	Profit Loss ProfitLoss	-111560000
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	36784000
CY2020	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	630000
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2600000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	99871000
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	61808000
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2634000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	53054000
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	59218000
CY2019	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-5805000
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-123821000
CY2018	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2183000
CY2019Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	646000
CY2019Q4	agen	Liability Related To Sale Of Future Royalties And Milestones Payment Current LiabilityRelatedToSaleOfFutureRoyaltiesAndMilestonesPaymentCurrent	45961000
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	29174000
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1950000
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1347000
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	17015000
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	13564000
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	29057000
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	31332000
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6481000
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	185000
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	129884000
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	122209000
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	18879000
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	13380000
CY2020Q4	agen	Liability Related To Sale Of Future Royalties And Milestones Payment Non Current LiabilityRelatedToSaleOfFutureRoyaltiesAndMilestonesPaymentNonCurrent	176263000
CY2019Q4	agen	Liability Related To Sale Of Future Royalties And Milestones Payment Non Current LiabilityRelatedToSaleOfFutureRoyaltiesAndMilestonesPaymentNonCurrent	175408000
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	28282000
CY2019Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	27705000
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	34065000
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	8020000
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	10208000
CY2019Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	8843000
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1514000
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4190000
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	196090980
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	137818068
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	1961000
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	1378000
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1257502000
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1059583000
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2772000
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1324000
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1465907000
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1284993000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-203672000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-225356000
CY2020Q4	us-gaap	Minority Interest MinorityInterest	-7826000
CY2019Q4	us-gaap	Minority Interest MinorityInterest	-5981000
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-211498000
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-231337000
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	214514000
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	4096000
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	215000
CY2020	agen	Comprehensive Income Loss Available To Common Stockholders Basic ComprehensiveIncomeLossAvailableToCommonStockholdersBasic	-177027000
CY2019	agen	Comprehensive Income Loss Available To Common Stockholders Basic ComprehensiveIncomeLossAvailableToCommonStockholdersBasic	-107650000
CY2018	agen	Comprehensive Income Loss Available To Common Stockholders Basic ComprehensiveIncomeLossAvailableToCommonStockholdersBasic	-159269000
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	155335000
CY2020	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-1221000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-117235000
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-70137000
CY2020	agen	Loss On Modification Of Debt LossOnModificationOfDebt	-2720000
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-10767000
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1858000
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	28000
CY2020	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-61078000
CY2019	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-41451000
CY2018	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-25273000
CY2018	us-gaap	Profit Loss ProfitLoss	-162044000
CY2018	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	207000
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.05
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	172504
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	134982
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	4096000
CY2019	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	215000
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	630000
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-75815000
CY2018	us-gaap	Profit Loss ProfitLoss	-162044000
CY2018	agen	Minority Interest Increase From Distributions To Noncontrolling Interest Holders MinorityInterestIncreaseFromDistributionsToNoncontrollingInterestHolders	274000
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7351000
CY2018	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	44919000
CY2018	agen	Shares Issued To Consultants In Value SharesIssuedToConsultantsInValue	50000
CY2018	agen	Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan StockIssuedDuringPeriodValueStockOptionsExercisedAndEmployeeStockPurchasePlan	1234000
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-174545000
CY2019	us-gaap	Profit Loss ProfitLoss	-111560000
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	215000
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9892000
CY2019	agen	Stock Issued Under Stock Purchase Agreement Value StockIssuedUnderStockPurchaseAgreementValue	30000000
CY2019	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	12962000
CY2019	agen	Shares Issued To Consultants In Value SharesIssuedToConsultantsInValue	81000
CY2019	agen	Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan StockIssuedDuringPeriodValueStockOptionsExercisedAndEmployeeStockPurchasePlan	1643000
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-231337000
CY2020	us-gaap	Profit Loss ProfitLoss	-182891000
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	4096000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10121000
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	156421000
CY2020	agen	Stock Issued Under Stock Purchase Agreement Value StockIssuedUnderStockPurchaseAgreementValue	20000000
CY2020	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	2374000
CY2020	agen	Issuance Of Shares Value For Business Acquisition IssuanceOfSharesValueForBusinessAcquisition	900000
CY2020	agen	Payment Of Ceo Payroll In Shares Value PaymentOfCEOPayrollInSharesValue	296000
CY2020	agen	Shares Issued To Consultants In Value SharesIssuedToConsultantsInValue	908000
CY2020	agen	Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan StockIssuedDuringPeriodValueStockOptionsExercisedAndEmployeeStockPurchasePlan	4469000
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2767000
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-234000
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5366000
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-11464000
CY2019	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	53900000
CY2018	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-397000
CY2020	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	2175000
CY2020	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	3826000
CY2019	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	7097000
CY2018	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	3303000
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-211498000
CY2020	us-gaap	Profit Loss ProfitLoss	-182891000
CY2019	us-gaap	Profit Loss ProfitLoss	-111560000
CY2018	us-gaap	Profit Loss ProfitLoss	-162044000
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7179000
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6662000
CY2018	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6288000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	10417000
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	9892000
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	7625000
CY2020	agen	Non Cash Royalty And Milestone Revenue NonCashRoyaltyAndMilestoneRevenue	47545000
CY2019	agen	Non Cash Royalty And Milestone Revenue NonCashRoyaltyAndMilestoneRevenue	30424000
CY2018	agen	Non Cash Royalty And Milestone Revenue NonCashRoyaltyAndMilestoneRevenue	17309000
CY2020	agen	Non Cash Interest Expense NonCashInterestExpense	60029000
CY2019	agen	Non Cash Interest Expense NonCashInterestExpense	42201000
CY2018	agen	Non Cash Interest Expense NonCashInterestExpense	24599000
CY2020	agen	Donation Of Assets DonationOfAssets	622000
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-198000
CY2019	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-58000
CY2018	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-145000
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1221000
CY2019	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	5805000
CY2018	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1335000
CY2020	agen	Loss On Modification Of Debt LossOnModificationOfDebt	-2720000
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-10767000
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-16187000
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	15355000
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-196000
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-55000
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-24000
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	187000
CY2019	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-11792000
CY2018	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	8210000
CY2019	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-1429000
CY2018	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	113000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-139096000
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18682000
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-131095000
CY2018	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	6000
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4657000
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3597000
CY2020	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	975000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4441000
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4657000
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3591000
CY2020	agen	Proceeds From Employee Stock Purchases And Option Exercises ProceedsFromEmployeeStockPurchasesAndOptionExercises	4469000
CY2019	agen	Proceeds From Employee Stock Purchases And Option Exercises ProceedsFromEmployeeStockPurchasesAndOptionExercises	1643000
CY2018	agen	Proceeds From Employee Stock Purchases And Option Exercises ProceedsFromEmployeeStockPurchasesAndOptionExercises	1234000
CY2018	agen	Proceeds From Sale Of Future Royalties ProceedsFromSaleOfFutureRoyalties	204878000
CY2018	agen	Payments For Transaction Costs From Sale Of Future Royalties And Milestones PaymentsForTransactionCostsFromSaleOfFutureRoyaltiesAndMilestones	494000
CY2018	us-gaap	Repayments Of Debt RepaymentsOfDebt	161847000
CY2020	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	1770000
CY2019	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	320000
CY2018	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	283000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	183855000
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	31323000
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	128286000
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	379000
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	770000
CY2018	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-733000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	40697000
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8754000
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7133000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	61808000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	53054000
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	60187000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	102505000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	61808000
CY2020	us-gaap	Interest Paid Net InterestPaidNet	1176000
CY2019	us-gaap	Interest Paid Net InterestPaidNet	1224000
CY2018	us-gaap	Interest Paid Net InterestPaidNet	1171000
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	289000
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020	agen	Issuance Of Common Stock In Connection With Business Acquisition IssuanceOfCommonStockInConnectionWithBusinessAcquisition	900000
CY2020	agen	Business Acquisition Deferred Purchase Price And Contingent Consideration BusinessAcquisitionDeferredPurchasePriceAndContingentConsideration	144000
CY2020	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	2374000
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	28184000
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3017000
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	2434000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	99900000
CY2020	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	38100000
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1470000000
CY2020	agen	Number Of Subsidiaries Not Owned NumberOfSubsidiariesNotOwned	2
CY2020	agen	Percentage Of Subsidiaries Not Owned PercentageOfSubsidiariesNotOwned	1
CY2020	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
CY2020	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<p style="margin-top:18pt;margin-bottom:0pt;text-indent:2.27%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">(c) Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. We base those estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances. Actual results could differ from those estimates.</p>
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-3100000
CY2019	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	100000
CY2018	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2200000
CY2019Q4	us-gaap	Goodwill Goodwill	23188000
CY2020	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	1470000
CY2020	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	794000
CY2020Q4	us-gaap	Goodwill Goodwill	25452000
CY2020	us-gaap	Indefinitelived Intangible Assets Acquired IndefinitelivedIntangibleAssetsAcquired	2132000
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	22727000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11841000
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10886000
CY2019	us-gaap	Indefinitelived Intangible Assets Acquired IndefinitelivedIntangibleAssetsAcquired	1945000
CY2019Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	19935000
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9431000
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10504000
CY2020	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P9Y
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2400000
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2000000.0
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2000000.0
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2200000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2200000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2200000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1700000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	600000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	600000
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	53054000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	102505000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	61808000
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	73991000
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	69187000
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	47201000
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	42861000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	26790000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	26326000
CY2020Q4	agen	Deferred Tax Assets Operating Loss Carry Forwards Federal And State DeferredTaxAssetsOperatingLossCarryForwardsFederalAndState	168786000
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	5302000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	14314000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	4846000
CY2020Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	39477000
CY2019Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	38710000
CY2020Q4	agen	Deferred Tax Assets Interest Expense Carryforward DeferredTaxAssetsInterestExpenseCarryforward	7114000
CY2019Q4	agen	Deferred Tax Assets Interest Expense Carryforward DeferredTaxAssetsInterestExpenseCarryforward	3893000
CY2020Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	58796000
CY2019Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	47456000
CY2020Q4	agen	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	8389000
CY2019Q4	agen	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	2002000
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	4768000
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3974000
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	311792000
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	264395000
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	303747000
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	262228000
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	8045000
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2167000
CY2020Q4	agen	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets Foreign DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssetsForeign	1052000
CY2019Q4	agen	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets Foreign DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssetsForeign	1009000
CY2020Q4	agen	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	7852000
CY2019Q4	agen	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	1599000
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	192000
CY2019Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	165000
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	9096000
CY2019Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2773000
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1051000
CY2019Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	606000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-38706000
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-23413000
CY2018	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-34029000
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	41519000
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	7913000
CY2018	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	24233000
CY2020	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-764000
CY2019	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-64000
CY2018	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	7000
CY2020	agen	Income Tax Reconciliation Foreign Income Inclusion IncomeTaxReconciliationForeignIncomeInclusion	3570000
CY2018	agen	Income Tax Reconciliation Foreign Income Inclusion IncomeTaxReconciliationForeignIncomeInclusion	11089000
CY2020	us-gaap	Income Tax Reconciliation Tax Contingencies State And Local IncomeTaxReconciliationTaxContingenciesStateAndLocal	-4675000
CY2019	us-gaap	Income Tax Reconciliation Tax Contingencies State And Local IncomeTaxReconciliationTaxContingenciesStateAndLocal	4144000
CY2018	us-gaap	Income Tax Reconciliation Tax Contingencies State And Local IncomeTaxReconciliationTaxContingenciesStateAndLocal	-11708000
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	1883000
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	1367000
CY2018	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	4219000
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	629000
CY2019	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-564000
CY2018	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	956000
CY2020	agen	Income Tax Reconciliation Income Tax Expense Benefit Change In Fair Value Of Contingent Consideration IncomeTaxReconciliationIncomeTaxExpenseBenefitChangeInFairValueOfContingentConsideration	287000
CY2019	agen	Income Tax Reconciliation Income Tax Expense Benefit Change In Fair Value Of Contingent Consideration IncomeTaxReconciliationIncomeTaxExpenseBenefitChangeInFairValueOfContingentConsideration	1219000
CY2018	agen	Income Tax Reconciliation Income Tax Expense Benefit Change In Fair Value Of Contingent Consideration IncomeTaxReconciliationIncomeTaxExpenseBenefitChangeInFairValueOfContingentConsideration	-280000
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-3743000
CY2019	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	9398000
CY2018	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	5513000
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4292000
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4356000
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4349000
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	88000
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	122000
CY2020	agen	Unrecognized Tax Benefits Increases Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions	-766000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3614000
CY2019	agen	Unrecognized Tax Benefits Increases Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions	-186000
CY2018	agen	Unrecognized Tax Benefits Increases Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions	7000
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4292000
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4356000
CY2020Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	7643000
CY2019Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	9575000
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4457000
CY2019Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4314000
CY2020Q4	agen	Accrued Contract Manufacturing Costs AccruedContractManufacturingCosts	6274000
CY2019Q4	agen	Accrued Contract Manufacturing Costs AccruedContractManufacturingCosts	8768000
CY2020Q4	agen	Accrued Research Services Current AccruedResearchServicesCurrent	4649000
CY2019Q4	agen	Accrued Research Services Current AccruedResearchServicesCurrent	6675000
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6034000
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2000000
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	29057000
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	31332000
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	240000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.66
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.64
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.64
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.008
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.018
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.028
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	27164147
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.67
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	7330377
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.82
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1161757
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.05
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	2974728
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9892000
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.30
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	1441638
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	4.52
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	28916401
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.70
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	7088129
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	28916401
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	3.70
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	7088129
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	14997220
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	3.98
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	3232022
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.04
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.77
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.23
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1200000
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	385000
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	399000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2207943
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.85
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	179816
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.60
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	165632
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	2.75
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	1335311
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	3.43
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	886816
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.14
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	621000
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	357000
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	242000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	165632
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	129675
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	53050
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10121000
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7625000
CY2020Q4	agen	Estimate Of Payments For Clinical Trials EstimateOfPaymentsForClinicalTrials	385500000
CY2020	agen	Clinical Trials Expense ClinicalTrialsExpense	64700000
CY2019	agen	Clinical Trials Expense ClinicalTrialsExpense	87700000
CY2018	agen	Clinical Trials Expense ClinicalTrialsExpense	41500000
CY2020Q4	agen	Cumulative Payments For Clinical Trials CumulativePaymentsForClinicalTrials	308100000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	88170000
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	150048000
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	36784000
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2019Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	56414000
CY2020	agen	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	1400000
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	12530000
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	45284000
CY2020Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	0
CY2020	agen	Finance Lease Expiration Period FinanceLeaseExpirationPeriod	2022
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	4698000
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	2551000
CY2020	agen	Finance Lease Cost FinanceLeaseCost	375000
CY2019	agen	Finance Lease Cost FinanceLeaseCost	221000
CY2020Q4	agen	Expected Sublease Receipts Payments To Be Received ExpectedSubleaseReceiptsPaymentsToBeReceived	1208000
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	1600000
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	1887000
CY2019	us-gaap	Variable Lease Cost VariableLeaseCost	1414000
CY2020	us-gaap	Sublease Income SubleaseIncome	578000
CY2019	us-gaap	Sublease Income SubleaseIncome	561000
CY2020	us-gaap	Lease Cost LeaseCost	6382000
CY2019	us-gaap	Lease Cost LeaseCost	3625000
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	1400000
CY2020	agen	Finance Lease Payments FinanceLeasePayments	1800000
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	33480000
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7364000
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	33480000
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7364000
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1950000
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1347000
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	34065000
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	8020000
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	36015000
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	9367000
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2231000
CY2019Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	796000
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	746000
CY2019Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	148000
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	66000
CY2020Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	812000
CY2019Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	148000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	14813000
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	804000
CY2020Q4	agen	Expected Sublease Receipts Payments To Be Received Due Next Twelve Months ExpectedSubleaseReceiptsPaymentsToBeReceivedDueNextTwelveMonths	595000
CY2020Q4	agen	Net Future Lease Commitments Payments Due Next Twelve Months NetFutureLeaseCommitmentsPaymentsDueNextTwelveMonths	-14604000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	5007000
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	67000
CY2020Q4	agen	Expected Sublease Receipts Payments To Be Received Two Years ExpectedSubleaseReceiptsPaymentsToBeReceivedTwoYears	613000
CY2020Q4	agen	Net Future Lease Commitments Payments Due Year Two NetFutureLeaseCommitmentsPaymentsDueYearTwo	4461000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	9486000
CY2020Q4	agen	Net Future Lease Commitments Payments Due Year Three NetFutureLeaseCommitmentsPaymentsDueYearThree	9486000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	8279000
CY2020Q4	agen	Net Future Lease Commitments Payments Due Year Four NetFutureLeaseCommitmentsPaymentsDueYearFour	8279000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	8473000
CY2020Q4	agen	Net Future Lease Commitments Payments Due Year Five NetFutureLeaseCommitmentsPaymentsDueYearFive	8473000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	85638000
CY2020Q4	agen	Net Future Lease Commitments Payments Due After Year Five NetFutureLeaseCommitmentsPaymentsDueAfterYearFive	85638000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	102070000
CY2020Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	871000
CY2020Q4	agen	Net Future Lease Commitments Payments Due NetFutureLeaseCommitmentsPaymentsDue	101733000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	66055000
CY2020Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	59000
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	36015000
CY2020Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	812000
CY2020Q4	agen	Expected Lease Incentives To Be Received Due Next Twelve Months ExpectedLeaseIncentivesToBeReceivedDueNextTwelveMonths	19200000
CY2020Q4	agen	Expected Lease Incentives To Be Received Two Years ExpectedLeaseIncentivesToBeReceivedTwoYears	2100000
CY2020Q4	us-gaap	Nonfinancial Liabilities Fair Value Disclosure NonfinancialLiabilitiesFairValueDisclosure	10208000
CY2019Q4	agen	Contingent Consideration Liability Fair Value Disclosure ContingentConsiderationLiabilityFairValueDisclosure	8843000
CY2019Q4	us-gaap	Nonfinancial Liabilities Fair Value Disclosure NonfinancialLiabilitiesFairValueDisclosure	8843000
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.120
CY2020Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.123
CY2020Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	687000
CY2020Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	19712000
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	20000000.0
CY2019Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	14146000
CY2019Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	120000
CY2019Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	14026000
CY2020Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	675000
CY2020Q1	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2020Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.48
CY2020Q1	agen	Price Per Share Premium To Average Closing Price Percentage PricePerSharePremiumToAverageClosingPricePercentage	0.20
CY2019Q4	agen	Liability Related To Sale Of Future Royalties And Milestones Including Unamortized Transaction Costs LiabilityRelatedToSaleOfFutureRoyaltiesAndMilestonesIncludingUnamortizedTransactionCosts	221845000
CY2020	agen	Non Cash Royalty And Milestone Revenue Recognized NonCashRoyaltyAndMilestoneRevenueRecognized	47545000
CY2020	agen	Non Cash Interest Expense Related To Sale Of Future Royalties NonCashInterestExpenseRelatedToSaleOfFutureRoyalties	59741000
CY2020Q4	agen	Liability Related To Sale Of Future Royalties And Milestones Including Unamortized Transaction Costs LiabilityRelatedToSaleOfFutureRoyaltiesAndMilestonesIncludingUnamortizedTransactionCosts	234041000
CY2020Q4	agen	Liability Related To Sale Of Future Royalties Unamortized Transaction Costs LiabilityRelatedToSaleOfFutureRoyaltiesUnamortizedTransactionCosts	416000
CY2020Q4	agen	Liability Related To Sale Of Future Royalties And Milestones Net LiabilityRelatedToSaleOfFutureRoyaltiesAndMilestonesNet	233625000
CY2020Q4	agen	Contingent Consideration Liability Fair Value Disclosure ContingentConsiderationLiabilityFairValueDisclosure	10208000
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2020Q4	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	20000000.0
CY2019Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	14100000
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1100000
CY2019	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	922000
CY2018	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	617000
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1100000
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	922000
CY2018	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	617000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	88170000
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	150048000
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	36784000
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
CY2019Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2020Q4	us-gaap	Noncurrent Assets NoncurrentAssets	30913000
CY2019Q4	us-gaap	Noncurrent Assets NoncurrentAssets	27743000
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15128000
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	26945000
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14832000
CY2020Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	31265000
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-45271000
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-48244000
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-51646000
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-37730000
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-44726000
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-47532000
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-51205000
CY2020Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-37660000
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.31
CY2020Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.28
CY2020Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.28
CY2020Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.20
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	79891000
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15715000
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19940000
CY2019Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34502000
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	17435000
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-51867000
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-46277000
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	-30851000
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	18454000
CY2019Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-50686000
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-45526000
CY2019Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-30107000
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22

Files In Submission

Name	View Source	Status
0001564590-21-013619-index-headers.html	Edgar Link	pending
0001564590-21-013619-index.html	Edgar Link	pending
0001564590-21-013619.txt	Edgar Link	pending
0001564590-21-013619-xbrl.zip	Edgar Link	pending
agen-10k_20201231.htm	Edgar Link	pending
agen-10k_20201231_htm.xml	Edgar Link	completed
agen-20201231.xsd	Edgar Link	pending
agen-20201231_cal.xml	Edgar Link	unprocessable
agen-20201231_def.xml	Edgar Link	unprocessable
agen-20201231_lab.xml	Edgar Link	unprocessable
agen-20201231_pre.xml	Edgar Link	unprocessable
agen-ex211_6.htm	Edgar Link	pending
agen-ex231_16.htm	Edgar Link	pending
agen-ex311_13.htm	Edgar Link	pending
agen-ex312_14.htm	Edgar Link	pending
agen-ex321_9.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
g5lzl1kzrzvo000001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AGEN
AGENUS INC Stock $agen

2020 Q4 Form 10-K Financial Statement

#000156459021013619 Filed on March 16, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AGEN AGENUS INC Stock $agen

2020 Q4 Form 10-K Financial Statement

#000156459021013619 Filed on March 16, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AGEN
AGENUS INC Stock $agen